Navigation Links
HeartWare International Clinical Trial Shows 90% Survival at 180 Days
Date:4/24/2009

FRAMINGHAM, Mass. and SYDNEY, April 24 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR) (ASX: HIN) today announced updated results for its international clinical trial of the HeartWare(R) Left Ventricular Assist System. The results were presented by Dr. Martin Strueber, cardiothoracic surgeon at Hannover Medical School, at the annual meeting of the International Society for Heart and Lung Transplantation (ISHLT) held in Paris this week. A full copy of the presentation was filed as part of a form 8-K with the U.S. Securities and Exchange Commission and can be accessed at www.sec.gov.

The data presented at ISHLT includes all 50 patients enrolled in the trial across 5 participating centers. The data show a survival rate of 90% at 6 months and a survival rate of approximately 86% at 12 months post implant*. On average, the patients were supported by the HeartWare(R) System for 300 days each. The cumulative duration of support across the group exceeded 41 years. The patients' quality of life showed significant improvement at all points post-implant and the rates of adverse events were relatively low despite the unusually long average duration of pump support across the patient group.

"These results appear again to confirm the benefits we believe to be inherent in the design of this device," said HeartWare CEO, Mr. Doug Godshall. "At the ISHLT meeting 12 months ago we reported a 90% survival among our initial patient cohort. It is pleasing to observe that this success rate has been maintained over a far larger patient group and over a longer period of time. We anticipate these positive data providing a meaningful stimulus as we make the system more broadly available in our International markets and as we accelerate enrolment in our US Bridge to Transplant clinical
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
3. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
4. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
5. Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009
6. VIDEO from Medialink and International HIFU: New Prostate Cancer Procedure Being Tested in US Clinical Trials
7. Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients
8. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
9. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
10. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
11. In Vivo Data on Taligen Therapeutics Pipeline Candidates Presented at the XXII International Complement Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... how to optimize a product,s web presence to ... critical. Brand websites, in particular, must meet the ... in regulations and culture. According ... LLC, more than half of the participating companies ...
(Date:12/19/2014)...  Monarch America Inc. (OTCQB: CANK) ("Monarch America" or ... provide this review of the Company,s recent achievements and ... "Over this past year, we achieved many of our ... to say that Monarch America is in a stronger ... been," stated Eric Hagen , CEO of Monarch ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
Breaking Medicine Technology:Building a Best-in-Class Pharma Global Brand Website 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 2Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015 3The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... 2 MedAvante, Inc., the leader in centralized evaluation of central nervous ... Service for trials assessing Alzheimer,s Disease. Its CQC Services are already in use ... in the United States , Europe , Asia , ... , , ...
... HARBIN, China , June 2 /PRNewswire-Asia-FirstCall/ ... a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals and traditional Chinese ... a conference call at 9:00 a.m. Eastern Time ... for the second quarter of its,fiscal year 2010, ended ...
Cached Medicine Technology:MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimer's Disease Trials 2MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimer's Disease Trials 3Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 Second Quarter Results 3
(Date:12/21/2014)... Thompson HealthDay Reporter FRIDAY, ... e-cigarettes less addictive than traditional cigarettes, new research finds. ... did regular cigarettes, thousands of ex-smokers said they have fewer ... over their need to smoke, researchers reported. ... less for e-cig use than for tobacco use," said lead ...
(Date:12/21/2014)... AlignLife of Norton Shores is spreading ... same time helping people get their health back. Mission ... to serving those persons in Muskegon County who are unable ... quality of life. Dr. Michael Rykse wanted to do a ... community and he knew he found that when he heard ...
(Date:12/21/2014)... Over the past 39 years, NES Health ... emergency departments across the nation, from quality of medical ... into an innovative suite of tools, systems, and programs ... the patient experience. , NES Health, a leading ... services for hospitals, announced the development and launch of ...
(Date:12/21/2014)... 21, 2014 As testosterone therapy ... attacks, stroke and blood clots from using testosterone products ... new study shows that the male hormone testosterone may ... a study published in the Proceedings of the National ... examined a group of male rats with naturally occurring ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Concept Plus, LLC. ... engineering firm headquartered in Fairfax, VA., today announced it ... its Fast 50 list, which ranks the fastest growing government ... from 2009 to 2013. , This is the first year ... it ranked # 20 with a 95.92% compound annual growth ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 2Health News:E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds 3Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2
... volunteers, researchers say , TUESDAY, May 11 (HealthDay News) -- ... German researchers tested pain responses in 24 healthy volunteers and ... years ago, increased pain thresholds by up to 50 percent. ... (contralateral) leg. , The study also found that two types ...
... can remain, and heart risks fall , TUESDAY, May 11 ... Close Encounters of the Third Kind was in theaters ... was the year Lawrence Golding, now 81, a professor of ... no-frills, boot-camp-style exercise class for men, held weekdays at lunchtime ...
... ... , ... 11, 2010 -- Richard Marbes, Chairman of the Disabled American Veterans (DAV) Charitable Services Trust ... pleased to advise that favorable consideration was given to the funding request for USA Cares ...
... ... take when facing a personal problem or needing personal advice? What would others do if ... is to serve as a personal advice device to help people learn what others in their ... ...
... ... current and future market trends, convergence, and strategic partnerships from a panel representing different sectors ... ... Industry presentation on Thursday, May 27 at 8:00am in Room 33 of the Donald E. ...
... ... winning products to parents everywhere. , ... (PRWEB) May 11, 2010 -- Companies that submitted products for testing by PTPA Media ... Summer 2010 are here and they’re smart, fun, innovative, and so cool they’re actually hot! ...
Cached Medicine News:Health News:With Long-Term Exercise, Being 80 Is Just a Number 2Health News:With Long-Term Exercise, Being 80 Is Just a Number 3Health News:Disabled American Veterans Charitable Services Trust Supports OIF/OEF Veterans Battling PTSD 2Health News:Quilmach LLC Announces the Introduction of QUILMACH.COM, the first Community Based Personal Advice Device on the Web 2Health News:Quilmach LLC Announces the Introduction of QUILMACH.COM, the first Community Based Personal Advice Device on the Web 3Health News:PSA-TEC to Present State of the Industry Panel Discussion 2Health News:Parent Tested Parent Approved Media Announces their Winning Products for the Summer 2010 Campaign 2
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes...
... slit lamp is a ... that is designed with ... and has standard 10X ... design provides increased optical ...
... is designed to for use with digital ... offers the popular horizontal style light source. ... family of slit lamps that offers the ... clear, crisp digital images in the most ...
... The first slit lamp truly designed ... for digital video imaging. No other slit ... features of this exceptional product. The ReSeeVit ... product on the market to allow capture ...
Medicine Products: